Inappropriate Fentanyl Prescribing Among Nursing Home Residents in the United States

Journal of the American Medical Directors Association

Volumn 18, Issue 2, 2017, Pages 138-144

  Fain, Kevin M ^a   Castillo Salgado, Carlos ^a   Dore, David D ^b,c   Segal, Jodi B ^a,d   Zullo, Andrew R ^c   Alexander, G Caleb ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b OPTUM   (United States)

^c BROWN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fentanyl; Food and Drug Administration; Nursing homes; prescription opioids

Indexed keywords

FENTANYL; OPIATE; NARCOTIC ANALGESIC AGENT;

AGE; AGED; ARTHRITIS; ARTICLE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; MEDICARE; NURSING HOME PATIENT; PAIN SEVERITY; SENSITIVITY ANALYSIS; UNITED STATES; FOOD AND DRUG ADMINISTRATION; NURSING HOME; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; FENTANYL; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; NURSING HOMES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84991773741     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.08.015     Document Type: Article

References (49)

1. 1 Fain, K., Alexander, G.C., Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiol Drug Saf 22 (2013), 1258–1262.
2. 2 US Food and Drug Administration. Califf, FDA top officials call for sweeping review of agency opioid policies. 2016 Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm484765.htm Accessed September 22, 2016.
3. 3 Centers for Disease Control and Prevention. Increases in drug and opioid overdose deaths: United States, 2000–2014. MMWR Morb Mortal Wkly Rep 64 (2016), 1378–1382.
4. 4 Jena, A.B., Goldman, D., Weaver, L., Karaca-Mandic, P., Opioid prescribing by multiple providers in Medicare: Retrospective observational study of insurance claims. BMJ, 348, 2014, g1393.
5. 5 American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Adults. Pharmacological management of persistent pain in older adults. J Am Geriatr Soc 57 (2009), 1331–1346.
6. 6 Reisner, L., Pharmacological management of persistent pain in older persons. J Pain 12 (2011), S21–S29.
7. 7 Field, T.S., Gurwitz, J.H., Avorn, J., et al. Risk factors for adverse events among nursing home residents. Arch Intern Med 161 (2001), 1629–1631.
8. 8 Gurwitz, J.H., Field, T.S., Avorn, J., et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 109 (2000), 87–94.
9. 9 Cool, C., Cestac, P., Laborde, C., et al. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc 15 (2014), 850.e1–850.e9.
10. 10 Centers for Medicare and Medicaid Services. Nursing Home Compendium. 2010, US Centers for Medicare and Medicaid, Washington, DC.
11. 11 Lapane, K.L., Quilliam, B.J., Chow, W., Kim, M.S., Pharmacologic management of non-cancer pain among nursing home residents. J Pain Symptom Manage 45 (2013), 33–42.
12. 12 Won, A.B., Vallow, S., Schein, J., et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 52 (2004), 867–874.
13. 13 Dosa, D.M., Dore, D.D., Mor, V., Teno, J.M., Frequency of long-acting opioid analgesic initiation in opioid-naive nursing home residents. J Pain Symptom Manage 38 (2009), 515–521.
14. 14 US Food and Drug Administration. FDA News Release: FDA Issues Second Safety Warning on Fentanyl Skin Patch. 2007 Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109046.htm Accessed February 27, 2016.
15. 15 US Food and Drug Administration. FDA approved Duragesic labeling. 2005 Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/19813s039lbl.pdf Accessed February 27, 2016.
16. 16 US Food and Drug Administration. FDA approved Duragesic labeling. 2008 Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019813s033lbl.pdf Accessed February 27, 2016.
17. 17 US Food and Drug Administration. Public health advisory: Safety warnings regarding use of fentanyl transdermal (skin) patches. 2005 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm051739.htm Accessed February 27, 2016.
18. 18 US Food and Drug Administration. FDA public health advisory: Important information for the safe use of fentanyl transdermal system (patch). 2007 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm051257.htm Accessed February 27, 2016.
19. 19 US Food and Drug Administration. Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics) 07/15/05. 2005 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm125844.htm Accessed February 26, 2016.
20. 20 US Food and Drug Administration. Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics) - 12/21/2007 Update. 2007 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm084307.htm Accessed February 26, 2016.
21. 21 Pimentel, C.B., Gurwitz, J.H., Tjia, J., et al. New initiation of long-acting opioids in long-stay nursing home residents. J Am Geriatr Soc 64 (2016), 1772–1778.
22. 22 Reynolds, K.S., Hanson, L.C., DeVellis, R.F., et al. Disparities in pain management between cognitively intact and cognitively impaired nursing home residents. J Pain Symptom Manage 35 (2008), 388–396.
23. 23 Centers for Medicare and Medicaid Services. Resident Assessment Instrument 2.0 Manual. 2002, US Centers for Medicare and Medicaid, Washington, DC.
24. 24 Institute of Medicine. Improving the quality of long-term care. 2001, National Academies Press, Washington, DC.
25. 25 Straker, J.K., Bailer, A.J., A review and characterization of the MDS process in nursing homes. J Gerontol Nurs 34 (2008), 36–44.
26. 26 Carpenter, G.I., Hastie, C.L., Morris, J.N., et al. Measuring change in activities of daily living in nursing home residents with moderate to severe cognitive impairment. BMC Geriatr, 6, 2006, 7.
27. 27 Morris, J.N., Fries, B.E., Mehr, D.R., et al. MDS cognitive performance scale. J Gerontol 49 (1994), M174–M182.
28. 28 Mor, V., A Comprehensive clinical assessment tool to inform policy and practice. Med Care, 42, 2004 III-50–III-59.
29. 29 Kash, B.A., Hawes, C., Phillips, C.D., Comparing staffing levels in the Online Survey Certification and Reporting (OSCAR) system with the Medicaid cost report data: Are differences systematic?. Gerontologist 47 (2007), 480–489.
30. 30 Centers for Medicare and Medicaid Services. CMS Guide to Requests for Medicare Part D Prescription Drug Event (PDE) Data. 2008, US Centers for Medicare and Medicaid, Washington, DC.
31. 31 Fries, B.E., Simon, S.E., Morris, J.N., et al. Pain in U.S. nursing homes: Validating a pain scale for the Minimum Data Set. Gerontologist 41 (2001), 173–179.
32. 32 Won, A., Lapane, K., Gambassi, G., Correlates and management of nonmalignant pain in the nursing home. J Am Geriatr Soc 47 (1999), 1–7.
33. 33 Luo, H., Zhang, X., Cook, B., et al. Racial/ethnic disparities in preventive care practice among U.S. nursing home residents. J Aging Health 26 (2014), 519–539.
34. 34 Cai, S., Feng, Z., Fennell, M.L., Mor, V., Despite small improvement, black nursing home residents remain less likely than whites to receive flu vaccine. Health Aff (Millwood) 30 (2011), 1939–1946.
35. 35 Comondore, V.R., Devereaux, P.J., Zhou, Q., et al. Quality of care in for-profit and not-for-profit nursing homes: Systematic review and meta-analysis. BMJ, 339, 2009, b2732.
36. 36 Spilsbury, K., Hewitt, C., Stirk, L., Bowman, C., The relationship between nurse staffing and quality of care in nursing homes: A systematic review. Int J Nurs Stud 48 (2011), 732–750.
37. 37 Mor, V., Zinn, J., Angelelli, J., et al. Driven to tiers: Socioeconomic and racial disparities in the quality of nursing home care. Milbank Q 82 (2004), 227–256.
38. 38 American Medical Directors Association. Pain management in the long-term care setting. 2011, National Guideline Clearinghouse, Washington, DC.
39. 39 Lapane, K.L., Quilliam, B.J., Chow, W., Kim, M., The association between pain and measures of well-being among nursing home residents. J Am Med Dir Assoc 13 (2012), 344–349.
40. 40 Lin, W.C., Lum, T.Y., Mehr, D.R., Kane, R.L., Measuring pain prevalence and intensity in nursing home residents. J Am Med Dir Assoc 7 (2006), 147–153.
41. 41 Engle, V.F., Graney, M.J., Chan, A., Accuracy and bias of licensed practical nurse and nursing assistant ratings of nursing home residents’ pain. J Gerontol A Biol Sci Med Sci 56 (2000), M405–M411.
42. 42 Institute of Medicine. Unequal Treatment. 2003, National Academy of Sciences, Washington, DC.
43. 43 van Ryn, M., Fu, S.S., Paved with good intentions: Do public health and human service providers contribute to racial/ethnic disparities in health?. Am J Public Health 93 (2003), 248–255.
44. 44 Alexander, G.C., Frattaroli, S., Gielen, A.C., (eds.) The Prescription Opioid Epidemic: An Evidence-Based Approach, 2015, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
45. 45 US Food and Drug Administration. Risk evaluation and mitigation strategy for extended-release and long-acting opioids. 2014 Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM311290.pdf Accessed February 27, 2016.
46. 46 Qato, D.M., Alexander, G.C., Post-marketing drug safety and the Food and Drug Administration's risk evaluation and mitigation strategies. JAMA 306 (2011), 1595–1596.
47. 47 Ersek, M., Jablonski, A., A mixed-methods approach to investigating the adoption of evidence. J Gerontol Nurs 40 (2014), 52–60.
48. 48 Swafford, K.L., Miller, L.L., Tsai, P.F., et al. Improving the process of pain care in nursing homes: A literature synthesis. J Am Geriatr Soc 57 (2009), 1080–1087.
49. 49 Stevenson, K.M., Dahl, J.L., Berry, P.H., et al. Institutionalizing effective pain management practices: Practice change programs to improve the quality of pain management in small health care organizations. J Pain Symptom Manage 31 (2006), 248–261.